Research
Obstetrics
The phenotype of spontaneous preterm birth: application of a clinical phenotyping tool

Presented, in part, in oral format at the 35th annual meeting of the Society for Maternal-Fetal Medicine, San Diego, CA, Feb. 2-7, 2015. The racing flag logo above indicates that this article was rushed to press for the benefit of the scientific community.
https://doi.org/10.1016/j.ajog.2015.02.010Get rights and content

Objective

Spontaneous preterm birth (SPTB) is a complex condition that is likely a final common pathway with multiple possible causes. We hypothesized that a comprehensive classification system appropriately could group women with similar STPB causes and could provide an explanation, at least in part, for the disparities in SPTB that are associated with race and gestational age at delivery.

Study Design

This was a planned analysis of a multicenter, prospective study of singleton SPTBs. Women with SPTB at <34 weeks’ gestation were included. We defined 9 potential SPTB phenotypes based on clinical data: infection/inflammation, maternal stress, decidual hemorrhage, uterine distention, cervical insufficiency, placental dysfunction, premature rupture of the membranes, maternal comorbidities, and familial factors. Each woman’s condition was evaluated for each phenotype. Delivery gestational age was compared between those with and without each phenotype. Phenotype profiles were also compared between women with very early (20.0-27.9 weeks’ gestation) SPTB vs those with early SPTB (28.0-34.0 weeks’ gestation) and between African American and white women. Statistical analysis was by t test and χ2 test, as appropriate.

Results

The phenotyping tool was applied to 1025 women with SPTBs who delivered at a mean 30.0 ± 3.2 (SD) weeks’ gestation. Of these, 800 women (78%) had ≥2 phenotypes. Only 43 women (4.2%) had no phenotypes. The 281 women with early SPTBs were more likely to have infection/inflammation, decidual hemorrhage, and cervical insufficiency phenotypes (all P ≤ .001). African American women had more maternal stress and cervical insufficiency but less decidual hemorrhage and placental dysfunction compared with white women (all P < .05). Gestational age at delivery decreased as the number of phenotypes that were present increased.

Conclusion

Precise SPTB phenotyping classifies women with SPTBs and identifies specific differences between very early and early SPTB and between African American and white women.

Section snippets

Materials and Methods

This was a planned analysis of a multicenter, prospectively collected case-control study of women enrolled in the Eunice Kennedy Shriver National Institute for Child Health and Human Development Genomic and Proteomic Network for Preterm Birth Research. Briefly, women were recruited across 8 clinical sites from November 2007 through January 2011. Cases consisted of women who delivered singleton pregnancies from 20.0-33.9 weeks’ gestation after the spontaneous onset of labor (PTB cases). Women

Results

The phenotyping tool (was applied to the data from 1025 women with SPTB at <34 weeks’ gestation, including 281 women with very early SPTB (20.0-27.9 weeks’ gestation; Table 1). Basic demographics and baseline characteristics, compared by delivery gestational age epoch, are shown in Table 2. Most of the women (800; 78%) met criteria for >1 phenotype, although 43 women (4%) had no evidence of any phenotypes (Table 3). We observed an inverse relationship between the number of phenotypes and

Comment

We have described and defined specific SPTB phenotypes and have used this classification system successfully to group a large cohort of women with SPTB at <34.0 weeks’ gestation. We found that nearly all women with PTB had at least 1 phenotype; the majority had some evidence of at least 2 distinct phenotypes. Additionally, we found that phenotypes vary with delivery gestational age and self-reported maternal race. Phenotype classification provides more detailed information beyond delivery

Acknowledgments

Data collected at participating sites of the Genomics and Proteomics Network were transmitted to Yale University, the data coordinating center (DCC) for the network, which stored, managed, and analyzed the data for this study. On behalf of the GPN, Dr Heping Zhang (DCC Principal Investigator) had full access to the clinical data in the study and takes responsibility for the integrity of the data.

We are indebted to our medical and nursing colleagues and the infants and their parents who agreed

References (19)

There are more references available in the full text version of this article.

Cited by (100)

  • Elevated midtrimester maternal plasma cytokines and preterm birth in patients with cerclage

    2022, American Journal of Obstetrics and Gynecology MFM
    Citation Excerpt :

    The use of a noninvasive inflammatory plasma cytokine panel during pregnancy may provide risk stratification regarding the timing of delivery after cerclage. Cervical insufficiency—defined as the inability of the cervix to retain a pregnancy in the midtrimester—is the most severe spontaneous preterm birth (SPTB) phenotype, often resulting in pre- or periviable delivery.1–3 Cervical cerclage is frequently used as a surgical modality for the management of cervical insufficiency or the prevention of early recurrent SPTB.2

View all citing articles on Scopus

Since the study was conducted, Dr Manuck has moved to the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, School of Medicine, Chapel Hill, NC. Dr Bukowski has moved to the Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT.

Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomic and Proteomic Network for Preterm Birth Research (U01-HD-050062; U01-HD-050078; U01-HD-050080; U01-HD-050088; U01-HD-050094) and by Eunice Kennedy Shriver NICHD grant number 5K23HD067224 (T.A.M.).

The National Institutes of Health, NICHD, and National Center for Advancing Translational Sciences provided grant support for the NICHD Genomics and Proteomics Network for Preterm Birth. Although NICHD staff had input into the study design, conduct, analysis, and manuscript drafting, the comments and views of the authors do not necessarily represent the views of NICHD.

M.S.E. serves on the scientific advisory board and holds stock in Sera Prognostics, a private company established to create a commercial test to predict preterm birth and other obstetric complications. The remaining authors report no conflict of interest.

Cite this article as: Manuck TA, Esplin MS, Biggio J, et al. The phenotype of spontaneous preterm birth: application of a clinical phenotyping tool. Am J Obstet Gynecol 2015;212:487.e1-11.

View full text